Prostate Cancer Reports
54

Volume 6 Supplement 2
March 2018

.

Home > Prostate Cancer Reports > Volume 6, Year 2018 > Supplement 2, March



CONTENTS



CASE REPORTS
DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
FOLLOW-UP, QUALITY OF LIFE
OVERALL MANAGEMENT
PROGNOSIS
TREATMENT





CASE REPORTS


Morgans AK.
Optimization of Risk Stratification in Localized Prostate Cancer.
J Clin Oncol. 2018 Jan 5:JCO2017762971. doi: 10.1200/JCO.2017.76.2971. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



DIAGNOSIS


Bauman G, Martin P, Thiessen JD, Taylor R, Moussa M, Gaed M, Rachinsky I, Kassam Z, Chin J, Pautler S, Lee TY, Valliant JF, Ward A.
[18F]-DCFPyL Positron Emission Tomography/Magnetic Resonance Imaging for Localization of Dominant Intraprostatic Foci: First Experience.
Eur Urol Focus. 2016 Oct 26. pii: S2405-4569(16)30147-X. doi: 10.1016/j.euf.2016.10.002. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Brembilla G, Dell'Oglio P, Stabile A, Ambrosi A, Cristel G, Brunetti L, Damascelli A, Freschi M, Esposito A, Briganti A, Montorsi F, Del Maschio A, De Cobelli F.
Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection.
Eur Radiol. 2017 Dec 21. doi: 10.1007/s00330-017-5229-6. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Derlin T, Schmuck S, Juhl C, Zörgiebel J, Schneefeld SM, Walte ACA, Hueper K, von Klot CA, Henkenberens C, Christiansen H, Thackeray JT, Ross TL, Bengel FM.
PSA-stratified detection rates for [68Ga]THP-PSMA, a novel probe for rapid kit-based 68Ga-labeling and PET imaging, in patients with biochemical recurrence after primary therapy for prostate cancer.
Eur J Nucl Med Mol Imaging. 2018 Jan 7. doi: 10.1007/s00259-017-3924-9. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




deSouza NM, Liu Y, Chiti A, Oprea-Lager D, Gebhart G, Van Beers BE, Herrmann K, Lecouvet FE.
Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group.
Eur J Cancer. 2018 Mar;91:153-163. doi: 10.1016/j.ejca.2017.12.012. Epub 2018 Jan 10.
Source | Abstract | Full text | Similar articles




Eiber M, Herrmann K, Fendler WP, Maurer T.
68Ga-labeled Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Imaging: The New Kid on the Block-Early or Too Early to Draw Conclusions?
Eur Urol. 2016 Dec;70(6):938-940. doi: 10.1016/j.eururo.2016.07.045. Epub 2016 Jul 29.
Comment on: Perera M, Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis. [Eur Urol. 2016]
Source | Abstract | Full text | Similar articles




Grignon DJ.
Prostate cancer reporting and staging: needle biopsy and radical prostatectomy specimens.
Mod Pathol. 2018 Jan;31(S1):S96-109. doi: 10.1038/modpathol.2017.167.
Source | Abstract | Full text | Similar articles




Hofman MS, Hicks RJ, Maurer T, Eiber M.
Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls.
Radiographics. 2018 Jan-Feb;38(1):200-217. doi: 10.1148/rg.2018170108.
Source | Abstract | Full text | Similar articles




Gaunay G, Patel V, Shah P, Moreira D, Hall SJ, Vira MA, Schwartz M, Kreshover J, Ben-Levi E, Villani R, Rastinehad A, Richstone L.
Role of multi-parametric MRI of the prostate for screening and staging: Experience with over 1500 cases.
Asian J Urol. 2017 Jan;4(1):68-74. doi: 10.1016/j.ajur.2016.09.011. Epub 2016 Nov 22.
Source | Abstract | Full text | Similar articles




Gaunay GS, Patel V, Shah P, Moreira D, Rastinehad AR, Ben-Levi E, Villani R, Vira MA.
Multi-parametric MRI of the prostate: Factors predicting extracapsular extension at the time of radical prostatectomy.
Asian J Urol. 2017 Jan;4(1):31-36. doi: 10.1016/j.ajur.2016.07.002. Epub 2016 Nov 19.
Source | Abstract | Full text | Similar articles




Giesel F, Will L, Lawal I, Lengana T, Kratochwil C, Vorster M, Neels O, Reyneke F, Haberkon U, Kopka K, Sathekge M.
Intra-individual comparison of 18F-PSMA-1007 and 18F-DCFPyL PET/CT in the prospective evaluation of patients with newly diagnosed prostate carcinoma: A pilot study.
J Nucl Med. 2017 Dec 21. pii: jnumed.117.204669. doi: 10.2967/jnumed.117.204669. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Papa N, Perera M, Hofman MS, Bolton D, Lawrentschuk N.
Reply to Fabio Zattoni, Filiberto Zattoni, and Laura Evangelista's Letter to the Editor re: Marlon Perera, Nathan Papa, Daniel Christidis, et al. Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:926-37.
Eur Urol. 2017 Feb;71(2):e66-e67. doi: 10.1016/j.eururo.2016.08.050. Epub 2016 Sep 3.
Source | Abstract | Full text | Similar articles




Perera M, Papa N, Christidis D, Wetherell D, Hofman MS, Murphy DG, Bolton D, Lawrentschuk N.
Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis.
Eur Urol. 2016 Dec;70(6):926-937. doi: 10.1016/j.eururo.2016.06.021. Epub 2016 Jun 28.
Source | Abstract | Full text | Similar articles




Schiavina R, Bianchi L, Borghesi M, Dababneh H, Chessa F, Pultrone CV, Angiolini A, Gaudiano C, Porreca A, Fiorentino M, De Groote R, D'Hondt F, De Naeyer G, Mottrie A, Brunocilla E.
MRI displays the prostatic cancer anatomy and improves the bundles management before robot assisted radical prostatectomy.
J Endourol. 2017 Dec 19. doi: 10.1089/end.2017.0701. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Zattoni F, Zattoni F, Evangelista L.
Re: Marlon Perera, Nathan Papa, Daniel Christidis, et al. Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:926-37.
Eur Urol. 2017 Feb;71(2):e64-e65. doi: 10.1016/j.eururo.2016.08.049. Epub 2016 Aug 31.
Source | Abstract | Full text | Similar articles



EPIDEMIOLOGY, RISK FACTORS, PREVENTION


Lutz SZ, Todenhöfer T, Wagner R, Hennenlotter J, Ferchl JM, Scharpf MO, Martus P, Staiger H, Fritsche A, Stenzl A, Häring HU, Heni M.
Higher prevalence of lymph node metastasis in prostate cancer in patients with diabetes.
Endocr Relat Cancer. 2018 Jan 12. pii: ERC-17-0465. doi: 10.1530/ERC-17-0465. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



FOLLOW-UP, QUALITY OF LIFE


Jo JK, Jeong SJ, Oh JJ, Lee SW, Lee S, Hong SK, Byun SS, Lee SE.
Effect of starting penile rehabilitation with sildenafil immediately after robot-assisted laparoscopic radical prostatectomy on erectile function recovery: a prospective randomized trial.
J Urol. 2018 Jan 4. pii: S0022-5347(18)30009-0. doi: 10.1016/j.juro.2017.12.060. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



OVERALL MANAGEMENT


Freedland SJ.
20 years-A retrospective of prostate cancer and prostatic diseases.
Prostate Cancer Prostatic Dis. 2017 Dec 19. doi: 10.1038/s41391-017-0025-6. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Komura K, Sweeney CJ, Inamoto T, Ibuki N, Azuma H, Kantoff PW.
Current treatment strategies for advanced prostate cancer.
Int J Urol. 2017 Dec 20. doi: 10.1111/iju.13512. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



PROGNOSIS


Ahmadzadehfar H, Schlolaut S, Fimmers R, Yordanova A, Hirzebruch S, Schlenkhoff C, Gaertner FC, Awang ZH, Hauser S, Essler M.
Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [177Lu]Lu-PSMA-617 radioligand therapy.
Oncotarget. 2017 Oct 7;8(61):103108-103116. doi: 10.18632/oncotarget.21600. eCollection 2017 Nov 28.
Source | Abstract | Full text | Similar articles




Amiya Y, Yamada Y, Sugiura M, Sasaki M, Shima T, Suzuki N, Nakatsu H, Murakami S, Shimazaki J.
Outcomes of patients older than 75 years with non-metastatic prostate cancer.
Asian J Urol. 2017 Apr;4(2):102-106. doi: 10.1016/j.ajur.2016.12.001. Epub 2017 Jan 3.
Source | Abstract | Full text | Similar articles




Faiena I, Kim S, Farber N, Kwon YS, Shinder B, Patel N, Salmasi AH, Jang T, Singer EA, Kim WJ, Kim IY.
Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkers.
Oncotarget. 2017 Sep 28;8(65):109783-109790. doi: 10.18632/oncotarget.21297. eCollection 2017 Dec 12.
Source | Abstract | Full text | Similar articles




Lohm G, Neumann K, Budach V, Wiegel T, Hoecht S, Gollrad J.
Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy : Prolongation of prostate-specific antigen doubling time in patients with subsequent biochemical progression.
Strahlenther Onkol. 2017 Dec 18. doi: 10.1007/s00066-017-1247-1. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




McKay RR, Montgomery B, Xie W, Zhang Z, Bubley GJ, Lin DW, Preston MA, Trinh QD, Chang P, Wagner AA, Mostaghel EA, Kantoff PW, Nelson PS, Kibel AS, Taplin ME.
Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade.
Prostate Cancer Prostatic Dis. 2017 Dec 20. doi: 10.1038/s41391-017-0009-6. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Murata Y, Tatsugami K, Yoshikawa M, Hamaguchi M, Yamada S, Hayakawa Y, Ueda K, Momosaki S, Sakamoto N.
Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer.
Int J Urol. 2018 Jan 8. doi: 10.1111/iju.13514. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Thoma C.
Prostate cancer: Predicting risk of metastasis after prostatectomy.
Nat Rev Urol. 2018 Jan 3. doi: 10.1038/nrurol.2017.228. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Tonttila PP, Kuisma M, Pääkkö E, Hirvikoski P, Vaarala MH.
Lesion size on prostate magnetic resonance imaging predicts adverse radical prostatectomy pathology.
Scand J Urol. 2018 Jan 1:1-5. doi: 10.1080/21681805.2017.1414872. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



TREATMENT


Herden J, Weissbach L.
Utilization of Active Surveillance and Watchful Waiting for localized prostate cancer in the daily practice.
World J Urol. 2018 Jan 12. doi: 10.1007/s00345-018-2175-0. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




McNamara M, Sweeney C, Antonarakis ES, Armstrong AJ.
The evolving landscape of metastatic hormone-sensitive prostate cancer: a critical review of the evidence for adding docetaxel or abiraterone to androgen deprivation.
Prostate Cancer Prostatic Dis. 2017 Dec 20. doi: 10.1038/s41391-017-0014-9. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Robinson D, Garmo H, Lissbrant IF, Widmark A, Pettersson A, Gunnlaugsson A, Adolfsson J, Bratt O, Nilsson P, Stattin P.
Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study.
Eur Urol. 2017 Dec 15. pii: S0302-2838(17)31031-X. doi: 10.1016/j.eururo.2017.11.039. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Stone L.
Prostate cancer: Rapid testosterone cycling reverses castration resistance.
Nat Rev Urol. 2018 Feb;15(2):67. doi: 10.1038/nrurol.2017.223. Epub 2018 Jan 3.
Source | Abstract | Full text | Similar articles




von Eyben FE, Roviello G, Kiljunen T, Uprimny C, Virgolini I, Kairemo K, Joensuu T.
Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review.
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):496-508. doi: 10.1007/s00259-017-3895-x. Epub 2017 Dec 16.
Source | Abstract | Full text | Similar articles